Skip to main content

Table 3 Show the prevalence and severity of depression, anxiety and hopelessness in the case and control group

From: Evaluating prevalence of depression, anxiety and hopelessness in patients with Vitiligo on an Iranian population

 CaseControlp-value
Severity of depression
 Minimal53 (53.0%)60 (60%)0.157
 Mild19 (19.0%)25 (25%)
 Moderate16 (16.0%)9 (9%)
 Severe12 (12.0%)6 (6%)
Severity of anxiety
 Minimal32 (32. 7%)49 (49.5%)0.015
 Mild27 (27.6%)30 (30.3%)
 Moderate25 (25.5%)15 (15.2%)
 Severe14 (14.3%)5 (5.1%)
Severity of hopelessness
 Minimal40 (40.0%)48 (48.5%)0.006
 Mild34 (34%)42 (42.4%)
 Moderate18 (18.0%)9 (9.1%)
 Severe8 (8.0%)0 (0%)